# Telemetría de Benchmark: Qwen3.5-9B

| Caso de Prueba | Condición | Tiempo Total (s) | Tokens Generados | Velocidad (tokens/s) |
| :--- | :---: | :---: | :---: | :---: |
| CASO_1_EXPANSION | SIN RAG | 33.98s | 1000 | **29.43 t/s** |
| CASO_1_EXPANSION | CON RAG | 33.62s | 1000 | **29.74 t/s** |
| CASO_2_REGRESION | SIN RAG | 33.44s | 1000 | **29.9 t/s** |
| CASO_2_REGRESION | CON RAG | 33.76s | 1000 | **29.62 t/s** |
| CASO_3_ESTABILIDAD | SIN RAG | 33.88s | 1000 | **29.52 t/s** |
| CASO_3_ESTABILIDAD | CON RAG | 33.63s | 1000 | **29.74 t/s** |


## Detalle de Diagnósticos Generados

### [SIN RAG] CASO_1_EXPANSION
**Latencia:** 33.98s | **Velocidad:** 29.43 t/s

Thinking Process:

1.  **Analyze the Request:**
    *   **Role:** Expert Clinical Assistant in Quantitative Dermatology.
    *   **Task:** Analyze the evolution between two dermatological photographic controls based on provided quantitative metrics.
    *   **Input Data:**
        *   Area Variation: +33.33% (Control 1: 4200.0 px -> Control 2: 5600.0 px).
        *   Circularity Variation: -0.19 (Control 1: 0.81 -> Control 2: 0.62).
    *   **Instructions:**
        1.  Conclude the morphometric evolution technically.
        2.  Issue a medical conduct recommendation based on available clinical guidelines.

2.  **Interpret the Data:**
    *   **Area Increase:** The lesion has grown significantly in size (33.33% increase). This is a critical metric in dermatology, often associated with malignancy progression (e.g., melanoma, SCC, BCC) or inflammatory expansion.
    *   **Circularity Decrease:** Circularity measures how round a shape is (0 = very irregular/linear, 1 = perfect circle). A drop from 0.81 to 0.62 indicates the lesion has become more irregular in shape (less circular, more jagged or asymmetric).
    *   **Combined Interpretation:** Significant growth + increased irregularity (loss of symmetry/circularity) are classic "ABC" criteria changes (Asymmetry, Border irregularity). This suggests active progression.

3.  **Drafting the Technical Conclusion (Morphometric Evolution):**
    *   Need to use precise terminology (morphometry, lesion expansion, geometric distortion).
    *   Highlight the magnitude of change: >30% area increase is substantial.
    *   Highlight shape change: Decrease in circularity implies border irregularity and asymmetry.
    *   Synthesis: The lesion demonstrates aggressive morphometric evolution characterized by significant volumetric expansion and loss of geometric regularity.

4.  **Drafting the Medical Recommendation (Clinical Conduct):**
    *   Based on guidelines (e.g., NCCN, EADV, AAD for melanoma or skin cancer).
    *   Key principle: Rapid growth + irregularity = High suspicion of malignancy or active pathology requiring intervention.
    *   Action: Urgent referral for histopathological evaluation (biopsy/excision).
    *   Monitoring: Stop routine surveillance, move to diagnostic workup.
    *   Patient communication: Inform about potential seriousness.

5.  **Refining the Tone:**
    *   Professional, clinical, objective, urgent but calm.
    *   Spanish language (as requested).

6.  **Step-by-Step Construction:**

    *   *Section 1: Análisis Morfométrico Técnico*
        *   Start with Area: +33.33% is a major increase. Mention "expansión volumétrica significativa".
        *   Move to Circularity: Drop from 0.81 to 0.62. Explain what this means (border irregularity, asymmetry).
        *   Conclusion: The lesion is evolving dynamically and negatively.

    *   *Section 2: Recomendación de Conducta Médica*
        *   Reference guidelines (e.g., ABCDE rule, NCCN).
        *   Recommendation: Biopsy/Excision. Do not wait.
        *   Urgency level: High priority.
        *   Follow-up: Re-evaluation after treatment or staging if malignant.

7.  **Review against Constraints:**
    *   Did I analyze the evolution? Yes.
    *   Did I conclude technically? Yes.
    *   Did I issue a recommendation based on guidelines? Yes.
    *   Is it in Spanish? Yes.
    *   Is the tone appropriate for an expert assistant? Yes.

8.  **Final Polish (Self-Correction/Enhancement):**
    *   Make sure to emphasize that pixel count depends on scale, but relative change is what matters here.
    *   Ensure the link between circularity and "border irregularity" is clear.
    *   Add a disclaimer that this is AI analysis supporting clinical judgment, not replacing it. (Important for medical safety).

9.  **Final Output Generation** (similar to the thought process above).

    *   *Structure:*
        1.  Título: Informe de Análisis Morfométrico y Recomendación Clínica.
        2.  Conclusión Técnica.
        3.  Recomendación de

---

### [CON RAG] CASO_1_EXPANSION
**Latencia:** 33.62s | **Velocidad:** 29.74 t/s

Thinking Process:

1.  **Analyze the Request:**
    *   **Role:** Expert Clinical Assistant in Quantitative Dermatology.
    *   **Task:** Analyze the evolution between two dermatological photographic controls based on provided quantitative metrics and retrieved clinical literature (RAG).
    *   **Input Data:**
        *   Area Variation: +33.33% (4200 px -> 5600 px).
        *   Circularity Variation: -0.19 (0.81 -> 0.62).
        *   Literature (RAG):
            *   [Criterio Morfométrico]: Decrease in circularity index (< -0.08 or absolute < 0.60) indicates loss of surface tension, festooned edges, notches, or asymmetric radial growth -> structural atypia criterion.
            *   [guia.pdf]: Prognosis of loco-regional involvement is an active area of study. If Breslow index > 0.5mm, risk of dissemination increases, requiring integral management by a multidisciplinary oncology committee.
    *   **Instructions:**
        1.  Technically conclude the morphometric evolution.
        2.  Issue a medical conduct recommendation based on available clinical guidelines.

2.  **Evaluate the Quantitative Metrics:**
    *   **Area:** Increased by 33.33%. This is significant growth (more than one-third increase).
    *   **Circularity:** Decreased from 0.81 to 0.62. The change is -0.19.
    *   **Literature Threshold:** The literature states that a decrease < -0.08 OR absolute circularity < 0.60 reflects structural atypia (loss of tension, festooned edges, etc.).
    *   **Comparison:**
        *   Delta Circularicity: -0.19 is less than -0.08 (threshold met).
        *   Absolute Circularicity: 0.62 is greater than 0.60 (threshold not strictly met by absolute value alone, but the delta is significant). However, combined with area growth, this indicates irregularity.
    *   **Interpretation:** The lesion is growing significantly and becoming more irregular (less circular). This aligns with the "Criterio Morfométrico" regarding structural atypia.

3.  **Evaluate the Clinical Literature (RAG):**
    *   One snippet mentions Breslow index > 0.5mm implies increased risk of dissemination and need for multidisciplinary committee.
    *   *Constraint Check:* The input data does *not* provide a Breslow index (depth of invasion). It only provides 2D metrics (Area, Circularity).
    *   *Action:* I must be careful not to diagnose melanoma depth based on 2D area/circularity alone. However, the literature snippet suggests that if there is suspicion of significant risk (implied by the atypia found), a multidisciplinary approach might be needed. But strictly speaking, without Breslow, I cannot confirm the >0.5mm criterion.
    *   *Correction/Refinement:* The prompt asks to issue a recommendation *according to available clinical guidelines*. The provided RAG mentions Breslow > 0.5mm as a trigger for multidisciplinary management. Since I don't have Breslow, I should focus on the morphometric atypia which suggests malignancy risk (e.g., melanoma or SCC). The literature snippet about Breslow is relevant context but I must not assume it applies unless I mention that further evaluation (like dermoscopy/biopsy) is needed to determine Breslow.
    *   *Wait, looking closer at the RAG:* The RAG text says "If the lesion has a Breslow index > 0.5mm...". It doesn't say "If morphometric changes occur...". However, the first snippet [Criterio Morfométrico] explicitly links circularity decrease to "structural atypia".
    *   *Synthesis:* The morphometric evolution shows structural atypia (circularity drop + area growth). This warrants clinical concern. The recommendation should focus on biopsy/excision and multidisciplinary evaluation if malignancy is suspected, acknowledging the Breslow guideline context without overstepping data limits.

4.  **Drafting the Response:**

    *   **Section 1: Technical Conclusion of Morphometric Evolution.**
        *   State the changes clearly (Area +33%, Circularity -0.19).
        *   Apply the [Criterio Morfométrico]: The circularity drop (-

---

### [SIN RAG] CASO_2_REGRESION
**Latencia:** 33.44s | **Velocidad:** 29.9 t/s

Thinking Process:

1.  **Analyze the Request:**
    *   **Role:** Expert Clinical Assistant in Quantitative Dermatology.
    *   **Task:** Analyze the evolution between two dermatological photographic controls based on provided quantitative metrics.
    *   **Input Data:**
        *   Area Variation: -100.0% (Control 1: 3150.0 px -> Control 2: 0.0 px).
        *   Circularity Variation: -0.77 (Control 1: 0.77 -> Control 2: 0.0).
    *   **Instructions:**
        1.  Conclude technically on the morphometric evolution.
        2.  Issue a medical conduct recommendation based on available clinical guidelines.

2.  **Interpret the Data:**
    *   **Area Variation (-100%):** The lesion area went from 3150 pixels to 0 pixels. This indicates complete resolution or disappearance of the measurable lesion in the second control.
    *   **Circularity Variation (-0.77):** Circularity is a measure of how round an object is (ranging from 0 to 1, where 1 is a perfect circle). A value of 0.77 suggests a somewhat rounded but irregular shape. A value of 0.0 in the second control aligns with the area being 0. If there is no lesion, circularity cannot be calculated or is effectively null/undefined in this context (often represented as 0 in automated analysis when segmentation fails or object is absent).
    *   **Conclusion:** The quantitative data strongly suggests complete clearance of the skin lesion between Control 1 and Control 2.

3.  **Formulate Technical Conclusion (Morphometric Evolution):**
    *   Need to describe the change objectively.
    *   "Complete resolution" or "Total clearance".
    *   Mention the metrics: Area reduction is absolute (-100%), circularity metric becomes null due to absence of target.
    *   Interpretation: The lesion has disappeared from the field of view or segmentation threshold, indicating successful therapeutic response or spontaneous regression (though therapy is implied in "controls").

4.  **Formulate Medical Conduct Recommendation:**
    *   **Guidelines:** Dermatology guidelines generally recommend follow-up after clearance to ensure no recurrence and to rule out malignancy if it was a suspicious lesion.
    *   **Scenario A: Benign Lesion (e.g., acne, eczema):** If the patient had a benign condition, complete resolution is good. Recommendation: Maintain current treatment, schedule routine follow-up (e.g., 3-6 months) to monitor for recurrence.
    *   **Scenario B: Suspicious/Malignant Lesion (e.g., melanoma, SCC):** If this was a lesion being monitored for regression or post-excision, complete disappearance is good. However, if it was a pigmented lesion disappearing without excision, it could be concerning (amelanotic transformation? spontaneous regression?). But usually, "controls" imply monitoring a treated condition.
    *   **Standard Guideline Approach:** Even with clearance, histopathological confirmation is key if the original diagnosis was uncertain. If confirmed benign, continue maintenance. If malignant, ensure margins are clear (though area 0 suggests excision or resolution).
    *   **Safest Recommendation:** Since I don't know the diagnosis (benign vs. malignant), I must advise caution. Complete clearance is a positive sign of efficacy. However, clinical correlation is essential.
    *   **Recommendation:** Continue current therapy if applicable. Schedule follow-up visit to confirm sustained remission and assess skin health. If the lesion was suspicious, consider biopsy confirmation if it reappears or if there's doubt about the nature of the disappearance (e.g., did it heal or was it misidentified?).
    *   **Refining the Recommendation:** Given the drastic change (0 px), this looks like a successful treatment outcome. The recommendation should focus on maintenance and monitoring for recurrence, while ensuring the diagnosis remains valid.

5.  **Drafting the Response (in Spanish):**
    *   *Tone:* Professional, clinical, objective.
    *   *Structure:*
        1.  Conclusion Técnica (Morphometric).
        2.  Recomendación de Conducta Médica.
    *   *Key Phrases:* "Resolución completa", "Remisión clínica", "Seguimiento", "Correlación clínico-patológica".

6.  **Review against Constraints:**
    *   Role: Expert Clinical Assistant.
    *   Language: Spanish.
    *   Input Data: Used correctly (Area -100

---

### [CON RAG] CASO_2_REGRESION
**Latencia:** 33.76s | **Velocidad:** 29.62 t/s

Thinking Process:

1.  **Analyze the Request:**
    *   **Role:** Expert Clinical Assistant in Quantitative Dermatology.
    *   **Task:** Analyze the evolution between two dermatological photographic controls based on provided quantitative metrics and retrieved clinical literature (RAG).
    *   **Input Data:**
        *   Metric: Area Variation = -100.0% (Control 1: 3150.0 px -> Control 2: 0.0 px).
        *   Metric: Circularity Variation = -0.77 (Control 1: 0.77 -> Control 2: 0.0).
        *   Literature (RAG):
            *   [Criterio Morfométrico]: Significant decrease in circularity index (delta < -0.08 or absolute < 0.60) reflects loss of surface tension, festooned edges, notches, or asymmetric radial growth, a criterion of structural atypia.
            *   [guia.pdf]: Prognosis of locoregional involvement is an active area of study. If lesion has Breslow index > 0.5mm, risk of dissemination increases, requiring integral management by a multidisciplinary oncology committee.
    *   **Instructions:**
        1.  Technically conclude the morphometric evolution.
        2.  Issue a medical conduct recommendation based on available clinical guidelines.

2.  **Evaluate the Data & Metrics:**
    *   **Area Variation:** -100%. This means the lesion disappeared completely (3150 px -> 0 px).
    *   **Circularity Variation:** -0.77. Control 1 was 0.77 (near perfect circle), Control 2 is 0.0. This aligns with the area disappearance.
    *   **Interpretation:** The lesion has resolved completely between Control 1 and Control 2.

3.  **Evaluate the Literature (RAG):**
    *   **[Criterio Morfométrico]:** Discusses circularity decrease as a sign of atypia/structural change (festooned edges, etc.). However, this metric is usually used to detect *change* in an existing lesion or to classify malignancy. A drop to 0.0 implies absence, not necessarily atypia in the context of disappearance.
    *   **[guia.pdf]:** Discusses Breslow index > 0.5mm and locoregional involvement (sentinel lymph node, melanoma thin). It mentions multidisciplinary committee management for high-risk lesions.

4.  **Synthesize Findings:**
    *   **Morphometric Evolution:** The quantitative data indicates complete resolution of the lesion (Area = 0, Circularity = 0). This is a significant change from Control 1.
    *   **Clinical Context:** The literature provided focuses on *atypia* and *risk stratification* for melanoma/metastasis (Breslow > 0.5mm). It does not explicitly address "complete resolution" as a standard outcome, but rather warns about high-risk features.
    *   **Conflict/Nuance:** The metrics show disappearance. The literature warns about malignancy risk based on size/depth. If the lesion disappeared spontaneously, it could be benign (e.g., inflammatory, resolving infection) OR it could be a treated lesion (surgery, therapy). However, without knowing if treatment was applied between controls, spontaneous regression is possible but less common for melanoma.
    *   **Critical Thinking:** The prompt asks to analyze the evolution based on the provided metrics and literature.
        *   Metric 1: Area -100% -> Lesion gone.
        *   Metric 2: Circularity -0.77 -> Shape lost (consistent with area loss).
        *   Literature 1: Low circularity = atypia risk. (Here, circularity is 0 because it's gone).
        *   Literature 2: Breslow > 0.5mm = high risk. (We don't have Breslow data in the metrics, only area/circularity).

    *   **Conclusion on Evolution:** The lesion has completely resolved or was removed. If this is a spontaneous resolution, it's unusual for malignant lesions without treatment. If treated, it's a response. However, the literature provided emphasizes risk stratification based on Breslow depth and locoregional involvement.
    *   **Recommendation:** Since the area is now 0, immediate surgical excision isn't needed *unless* there was a prior diagnosis of high-risk lesion (Breslow > 0.5mm) mentioned in the

---

### [SIN RAG] CASO_3_ESTABILIDAD
**Latencia:** 33.88s | **Velocidad:** 29.52 t/s

Thinking Process:

1.  **Analyze the Request:**
    *   **Role:** Expert Clinical Assistant in Quantitative Dermatology.
    *   **Task:** Analyze the evolution between two dermatological photographic controls based on provided quantitative metrics.
    *   **Input Data:**
        *   Area Variation: +1.79% (Control 1: 2800.0 px -> Control 2: 2850.0 px).
        *   Circularity Variation: -0.01 (Control 1: 0.84 -> Control 2: 0.83).
    *   **Instructions:**
        1.  Technically conclude the morphometric evolution.
        2.  Issue a medical conduct recommendation based on available clinical guidelines.

2.  **Evaluate the Metrics:**
    *   **Area Variation (+1.79%):** This indicates a slight increase in lesion size. In dermatology, an increase in area can be concerning (e.g., growth of a melanoma or inflammatory process), but 1.79% is relatively small depending on the absolute size and timeframe between controls. However, any measurable growth warrants attention.
    *   **Circularity Variation (-0.01):** Circularity measures how round an object is (value ranges from 0 to 1). A decrease from 0.84 to 0.83 means the shape is becoming slightly less circular (more irregular or elongated). Irregular borders are a potential sign of malignancy (e.g., asymmetry, border irregularity in the ABCDE criteria).
    *   **Combined Interpretation:** The lesion is growing slightly and its shape is becoming marginally more irregular. This suggests progression, even if subtle.

3.  **Formulate Technical Conclusion (Instruction 1):**
    *   Need to describe the morphometric changes objectively.
    *   Highlight that there is a measurable increase in surface area (+1.79%).
    *   Highlight the decrease in circularity (-0.01), indicating increased border irregularity or shape distortion.
    *   Contextualize: These changes suggest active evolution of the lesion, potentially pathological progression.

4.  **Formulate Medical Recommendation (Instruction 2):**
    *   Based on guidelines (e.g., NCCN, AAD, ESDM): Any measurable growth in a pigmented or suspicious lesion is a red flag.
    *   Even small changes can be significant if the baseline was suspicious.
    *   Recommendation should lean towards closer monitoring or biopsy depending on clinical context (which isn't fully provided, but I must act as an expert).
    *   Standard advice for growth + irregularity: Re-evaluation is needed. If high suspicion, excisional biopsy. If low suspicion, shorten follow-up interval.
    *   Given the role "Expert Clinical Assistant", I should recommend a specific action: Shortened follow-up or histopathological evaluation if clinical suspicion exists. Since I don't know the lesion type (melanoma vs. benign nevus), I must assume caution.
    *   Guideline reference: ABCDE criteria (Asymmetry, Border irregularity, Color, Diameter, Evolution). "Evolution" is key here.
    *   Recommendation: Schedule a closer follow-up (e.g., 3-6 months instead of 12) or consider biopsy if clinical features align with malignancy.

5.  **Drafting the Response (in Spanish):**
    *   *Tone:* Professional, clinical, objective.
    *   *Structure:*
        1.  Conclusion Técnica (Morphometric analysis).
        2.  Recomendación de Conducta Médica (Action plan).

    *   *Drafting Conclusion:*
        "La evolución morfométrica indica un crecimiento superficial del lesiòn (+1.79%) y una ligera pérdida de circularidad (-0.01), lo que sugiere una alteración en la forma y tamaño." -> Refine to be more technical. "Se observa progresión cuantitativa significativa..."

    *   *Drafting Recommendation:*
        "Según guías (NCCN/AAD)..." -> "Recomendación: Reevaluación clínica inmediata o reducción del intervalo de seguimiento."

6.  **Refining the Output:**
    *   Make sure to mention that quantitative data must be integrated with qualitative clinical assessment.
    *   Emphasize that Area +1.79% is clinically relevant growth if within a short timeframe (usually >20-30 days for significant change, but any growth is noted).
    *   Circularity drop implies border irregularity increase.
   

---

### [CON RAG] CASO_3_ESTABILIDAD
**Latencia:** 33.63s | **Velocidad:** 29.74 t/s

Thinking Process:

1.  **Analyze the Request:**
    *   **Role:** Expert Clinical Assistant in Quantitative Dermatology.
    *   **Task:** Analyze the evolution between two dermatological photographic controls based on provided quantitative metrics and retrieved clinical literature (RAG).
    *   **Input Data:**
        *   Area Variation: +1.79% (2800.0 px -> 2850.0 px).
        *   Circularity Variation: -0.01 (0.84 -> 0.83).
        *   Literature (RAG):
            *   [Criterio Morfométrico]: Significant decrease in circularity index (delta < -0.08 or absolute < 0.60) indicates loss of surface tension, festooned edges, notches, or asymmetric radial growth (structural atypia).
            *   [guia.pdf]: Prognosis of local-regional involvement is an active area of study. If Breslow index > 0.5mm, risk of dissemination increases, requiring integral management by a multidisciplinary oncology committee.
    *   **Instructions:**
        1.  Conclude technically on the morphometric evolution.
        2.  Issue a medical conduct recommendation based on available clinical guidelines.

2.  **Evaluate the Quantitative Metrics:**
    *   **Area:** Increased by 1.79%. This is a slight increase. In dermatology, growth is concerning, but 1.79% over an unspecified time interval (usually implied to be between two controls) needs context. However, strictly morphometrically, it's a positive variation in size.
    *   **Circularity:** Decreased by 0.01 (from 0.84 to 0.83).
        *   Current value: 0.83.
        *   Threshold for concern (per RAG): Delta < -0.08 OR Absolute < 0.60.
        *   Comparison: The change is -0.01, which is much smaller than the threshold of -0.08. The absolute value (0.83) is well above the threshold of 0.60.
    *   **Conclusion on Morphometry:** There is a slight increase in area and a negligible decrease in circularity that does not meet the criteria for structural atypia defined in the literature (delta < -0.08). The lesion remains relatively geometrically stable regarding shape, with minor growth.

3.  **Evaluate the Clinical Literature (RAG):**
    *   [Criterio Morfométrico]: Defines specific thresholds for "structural atypia" based on circularity changes. The current data does not meet these thresholds.
    *   [guia.pdf]: Discusses prognosis and Breslow index (>0.5mm) regarding metastatic risk and multidisciplinary management.
        *   *Critical Gap:* The input data does *not* provide the Breslow index (depth of invasion). It only provides 2D morphometric data (Area, Circularity).
        *   Therefore, I cannot apply the Breslow criterion directly to the provided numbers. I must acknowledge this limitation or focus on the morphometric stability while noting that depth assessment is needed for staging.

4.  **Drafting the Response - Section 1: Technical Conclusion on Morphometric Evolution:**
    *   State the changes clearly.
    *   Compare against the RAG thresholds.
    *   Interpretation: The area growth is mild (1.79%). The circularity change (-0.01) is clinically insignificant compared to the atypia threshold (-0.08). The lesion maintains a high degree of geometric regularity (circularity > 0.60).
    *   Verdict: Morphometrically stable regarding shape, with minor growth. No evidence of significant structural atypia based on circularity metrics alone.

5.  **Drafting the Response - Section 2: Medical Conduct Recommendation:**
    *   Based on [guia.pdf]: Since Breslow index is unknown from the input, I cannot recommend oncological committee referral based solely on depth. However, if this were a melanoma context (implied by "melanoma delgado" in RAG), growth warrants monitoring.
    *   Based on [Criterio Morfométrico]: Since the atypia criteria are not met, no immediate alarm for structural change is triggered by these specific metrics.
    *   Recommendation: Continue surveillance (follow-up). The slight area increase requires monitoring but doesn't trigger an immediate "high risk" protocol based *only* on these

---

